Arcaro A - Search Results

1

The phosphoinositide 3-kinase signaling pathway as a therapeutic target in grade IV brain tumors.

Höland K, Salm F, Arcaro A. Höland K, et al. Among authors: arcaro a. Curr Cancer Drug Targets. 2011 Oct;11(8):894-918. doi: 10.2174/156800911797264743. Curr Cancer Drug Targets. 2011. PMID: 21861842 Review.

2

IGF-IR: potential role in antitumor agents.

Guerreiro AS, Boller D, Doepfner KT, Arcaro A. Guerreiro AS, et al. Among authors: arcaro a. Drug News Perspect. 2006 Jun;19(5):261-72. doi: 10.1358/dnp.2006.19.5.985933. Drug News Perspect. 2006. PMID: 16941048 Free article. Review.

3

Protein kinase B modulates the sensitivity of human neuroblastoma cells to insulin-like growth factor receptor inhibition.

Guerreiro AS, Boller D, Shalaby T, Grotzer MA, Arcaro A. Guerreiro AS, et al. Among authors: arcaro a. Int J Cancer. 2006 Dec 1;119(11):2527-38. doi: 10.1002/ijc.22126. Int J Cancer. 2006. PMID: 16988940

4

Targeting mTOR signaling in lung cancer.

Marinov M, Fischer B, Arcaro A. Marinov M, et al. Among authors: arcaro a. Crit Rev Oncol Hematol. 2007 Aug;63(2):172-82. doi: 10.1016/j.critrevonc.2007.04.002. Epub 2007 May 30. Crit Rev Oncol Hematol. 2007. PMID: 17540577 Review.

5

Autocrine insulin-like growth factor-I signaling promotes growth and survival of human acute myeloid leukemia cells via the phosphoinositide 3-kinase/Akt pathway.

Doepfner KT, Spertini O, Arcaro A. Doepfner KT, et al. Among authors: arcaro a. Leukemia. 2007 Sep;21(9):1921-30. doi: 10.1038/sj.leu.2404813. Epub 2007 Jun 21. Leukemia. 2007. PMID: 17581609

6

Targeting receptor tyrosine kinase signaling in acute myeloid leukemia.

Doepfner KT, Boller D, Arcaro A. Doepfner KT, et al. Among authors: arcaro a. Crit Rev Oncol Hematol. 2007 Sep;63(3):215-30. doi: 10.1016/j.critrevonc.2007.05.005. Epub 2007 Jul 19. Crit Rev Oncol Hematol. 2007. PMID: 17658267 Review.

7

Targeting the phosphoinositide 3-kinase isoform p110delta impairs growth and survival in neuroblastoma cells.

Boller D, Schramm A, Doepfner KT, Shalaby T, von Bueren AO, Eggert A, Grotzer MA, Arcaro A. Boller D, et al. Among authors: arcaro a. Clin Cancer Res. 2008 Feb 15;14(4):1172-81. doi: 10.1158/1078-0432.CCR-07-0737. Clin Cancer Res. 2008. PMID: 18281552 Free article.

8

Targeting the PI3K p110alpha isoform inhibits medulloblastoma proliferation, chemoresistance, and migration.

Guerreiro AS, Fattet S, Fischer B, Shalaby T, Jackson SP, Schoenwaelder SM, Grotzer MA, Delattre O, Arcaro A. Guerreiro AS, et al. Among authors: arcaro a. Clin Cancer Res. 2008 Nov 1;14(21):6761-9. doi: 10.1158/1078-0432.CCR-08-0385. Clin Cancer Res. 2008. PMID: 18980969

9

Recent patents of gene sequences relative to the phosphatidylinositol 3-kinase/Akt pathway and their relevance to drug discovery.

Doepfner KT, Boller D, De Laurentiis A, Guerreiro AS, Marinov M, Arcaro A. Doepfner KT, et al. Among authors: arcaro a. Recent Pat DNA Gene Seq. 2007;1(1):9-23. doi: 10.2174/187221507779814461. Recent Pat DNA Gene Seq. 2007. PMID: 19075915 Review.

10

Targeting Myc in pediatric malignancies of the central and peripheral nervous system.

Grotzer MA, Castelletti D, Fiaschetti G, Shalaby T, Arcaro A. Grotzer MA, et al. Among authors: arcaro a. Curr Cancer Drug Targets. 2009 Mar;9(2):176-88. doi: 10.2174/156800909787580962. Curr Cancer Drug Targets. 2009. PMID: 19275758 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters